Industry Research Reports

Home > Reports > Chemical & Material > Global Dihydroartemisinin Market Insights, Forecast to 2031

Global Dihydroartemisinin Market Insights, Forecast to 2031

Industry: Chemical & Material

Published Date: 2025-06-04

Pages: 170 Pages

Report ld: 4751198

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Dihydroartemisinin market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.

The evolving U.S. tariff policy posed substantial volatility risks to global markets. This report provides a comprehensive assessment of trade barrier escalations and cross-border counterstrategies, analyzing their multidimensional impacts on industrial competition patterns, geo-economic integration, and transnational value chain realignments.

Dihydroartemisinin is an antimalarial drug derived from artemisinin, characterized by its high efficiency, low toxicity, and rapid efficacy. It holds significant application value in the field of malaria treatment, especially in combating drug-resistant malaria. The chemical structure of dihydroartemisinin provides better bioavailability and pharmacokinetic properties compared to artemisinin, enabling more effective absorption and metabolism in the human body. With the ongoing global efforts in malaria prevention and control, the market demand for dihydroartemisinin continues to grow. Its research and development prospects are broad. As an important antimalarial drug, dihydroartemisinin has significant strategic importance in the pharmaceutical field. Its research and development not only help improve the treatment outcomes for malaria patients but also make important contributions to global public health.

Market Development Opportunities & Main Driving Factors

The market development opportunities for dihydroartemisinin are mainly reflected in the following aspects. Firstly, the continuous global efforts in malaria prevention and control have provided a broad market space for dihydroartemisinin. Malaria, as a serious infectious disease, still poses a significant threat to human health, especially in Africa and Southeast Asia. With the increasing attention paid by governments and international organizations to malaria prevention and control, the market demand for dihydroartemisinin, as an effective antimalarial drug, will continue to grow. Secondly, the growing problem of malaria drug resistance has also increased the market's demand for new antimalarial drugs. Dihydroartemisinin has shown excellent performance in treating drug-resistant malaria, effectively combating the resistance of Plasmodium to traditional drugs, which provides strong support for its market promotion. In addition, with the continuous development and innovation of the global pharmaceutical market, the research and application of dihydroartemisinin have also received more attention and investment. Pharmaceutical companies are highly enthusiastic about the research and development of new antimalarial drugs, and governments and research institutions have also increased their support for related research, all of which provide a favorable external environment for the market development of dihydroartemisinin.

Market Challenges, Risks, & Restraints

Despite the broad market prospects for dihydroartemisinin, it also faces some challenges and risks. On the one hand, the production cost of dihydroartemisinin is relatively high, which to some extent limits its market penetration. The extraction and synthesis process of artemisinin is relatively complex, and the stability of raw material supply is also uncertain, which may lead to increased production costs and thus affect the price competitiveness of the product. On the other hand, market competition is also fierce. With the continuous expansion of the antimalarial drug market, more and more enterprises are entering this field, and market competition is becoming increasingly fierce. Dihydroartemisinin needs to continuously improve its competitiveness in terms of product quality, price, and brand to gain a foothold in the market. In addition, changes in policies and regulations may also have an impact on the market of dihydroartemisinin. Governments of various countries are constantly adjusting their regulatory policies for drugs, and are putting forward higher requirements for the quality, safety, and effectiveness of drugs. Dihydroartemisinin manufacturing enterprises need to closely monitor changes in policies and regulations, and adjust production strategies in a timely manner to ensure that products meet relevant standards.

Downstream Demand Trends

Looking at downstream demand, the application fields of dihydroartemisinin are mainly concentrated in malaria treatment and public health. With the continuous deepening of global malaria prevention and control efforts, the demand for dihydroartemisinin will show a steady growth trend. In malaria-endemic areas, the demand for dihydroartemisinin from medical institutions will continue to increase to meet the treatment needs of malaria patients. At the same time, public health institutions will also increase their procurement of dihydroartemisinin for the implementation of malaria prevention and control projects. In addition, with the increasing health awareness of people and the improvement of medical conditions, the demand for high-quality antimalarial drugs will also continue to grow. Dihydroartemisinin, as an efficient and low-toxicity antimalarial drug, will be favored by the market. In the future, the application scope of dihydroartemisinin may be further expanded. In addition to malaria treatment, it may also be applied in other related disease treatment fields. With the continuous progress of scientific research technology, the pharmacological effects and application value of dihydroartemisinin will be further explored, providing a broader space for its market development.

In terms of production side, this report researches the Dihydroartemisinin production, growth rate, market share by manufacturers and by region (region level and country level), from 2020 to 2025, and forecast to 2031.

In terms of consumption side, this report focuses on the sales of Dihydroartemisinin by region (region level and country level), by company, by Type and by Application. from 2020 to 2025 and forecast to 2031.

This report presents an overview of global market for Dihydroartemisinin, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2020 - 2025, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Dihydroartemisinin, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Dihydroartemisinin, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Dihydroartemisinin sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Dihydroartemisinin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Dihydroartemisinin sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Ion Science, Nanjing Rich Native Animal Products, Tobacco Products, Grey Essential Oils, Sanofi, KPC Pharmaceuticals, Guangxi Xiancaotang Pharmaceutical, Guilin Pharmaceutical, Kerui Nanhai Pharmaceutical, Shanghai Natural Bio-engineering, etc.

MARKET SEGMENTATION

By Company

Ion Science
Nanjing Rich Native Animal Products
Tobacco Products
Grey Essential Oils
Sanofi
KPC Pharmaceuticals
Guangxi Xiancaotang Pharmaceutical
Guilin Pharmaceutical
Kerui Nanhai Pharmaceutical
Shanghai Natural Bio-engineering
Novanat Bioresource
Botanical Extracts EPZ Ltd
Skant Healthcare
Micro Orgo Chem

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Pharmaceutical Grade
Industrial Grade

Segment by Application

Malaria Treatment
Scientific Research
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Dihydroartemisinin production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 3: Sales (consumption), revenue of Dihydroartemisinin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Dihydroartemisinin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 9: China by Type, and by Application, sales, and revenue for each segment.

Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dihydroartemisinin sales, revenue, price, gross margin, and recent development, etc.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 15: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Dihydroartemisinin Product Introduction

1.2 Market by Type

1.2.1 Global Dihydroartemisinin Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Pharmaceutical Grade

1.2.3 Industrial Grade

1.3 Market by Application

1.3.1 Global Dihydroartemisinin Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Malaria Treatment

1.3.3 Scientific Research

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Dihydroartemisinin Production

2.1 Global Dihydroartemisinin Production Capacity (2020-2031)

2.2 Global Dihydroartemisinin Production by Region: 2020 VS 2024 VS 2031

2.3 Global Production by Region

2.3.1 Global Dihydroartemisinin Production by Region (2020-2031)

2.3.2 Global Dihydroartemisinin Production Market Share by Region (2020-2031)

2.4 North America

2.5 Europe

2.6 China

2.7 Japan

3 Executive Summary

3.1 Global Dihydroartemisinin Revenue Estimates and Forecasts 2020-2031

3.2 Global Revenue by Region

3.2.1 Global Dihydroartemisinin Revenue by Region: 2020 VS 2024 VS 2031

3.2.2 Global Dihydroartemisinin Revenue by Region (2020-2031)

3.2.3 Global Dihydroartemisinin Revenue Market Share by Region (2020-2031)

3.3 Global Dihydroartemisinin Sales Estimates and Forecasts 2020-2031

3.4 Global Sales by Region

3.4.1 Global Dihydroartemisinin Sales by Region: 2020 VS 2024 VS 2031

3.4.2 Global Dihydroartemisinin Sales by Region (2020-2031)

3.4.3 Global Dihydroartemisinin Sales Market Share by Region (2020-2031)

3.5 US & Canada

3.6 Europe

3.7 China

3.8 Asia (excluding China)

3.9 Middle East, Africa and Latin America

4 Competition by Manufacturers

4.1 Global Sales by Manufacturers

4.1.1 Global Dihydroartemisinin Sales by Manufacturers (2020-2025)

4.1.2 Global Dihydroartemisinin Sales Market Share by Manufacturers (2020-2025)

4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Dihydroartemisinin in 2024

4.2 Global Revenue by Manufacturers

4.2.1 Global Dihydroartemisinin Revenue by Manufacturers (2020-2025)

4.2.2 Global Dihydroartemisinin Revenue Market Share by Manufacturers (2020-2025)

4.2.3 Global Top 10 and Top 5 Companies by Dihydroartemisinin Revenue in 2024

4.3 Global Dihydroartemisinin Sales Price by Manufacturers (2020-2025)

4.4 Global Key Players of Dihydroartemisinin, Industry Ranking, 2023 VS 2024

4.5 Analysis of Competitive Landscape

4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

4.5.2 Global Dihydroartemisinin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.6 Global Key Manufacturers of Dihydroartemisinin, Manufacturing Base Distribution and Headquarters

4.7 Global Key Manufacturers of Dihydroartemisinin, Product Offered and Application

4.8 Global Key Manufacturers of Dihydroartemisinin, Date of Enter into This Industry

4.9 Mergers & Acquisitions, Expansion Plans

5 Market Size by Type

5.1 Global Sales by Type

5.1.1 Global Dihydroartemisinin Historical Sales by Type (2020-2025)

5.1.2 Global Dihydroartemisinin Forecasted Sales by Type (2026-2031)

5.1.3 Global Dihydroartemisinin Sales Market Share by Type (2020-2031)

5.2 Global Revenue by Type

5.2.1 Global Dihydroartemisinin Historical Revenue by Type (2020-2025)

5.2.2 Global Dihydroartemisinin Forecasted Revenue by Type (2026-2031)

5.2.3 Global Dihydroartemisinin Revenue Market Share by Type (2020-2031)

5.3 Global Price by Type

5.3.1 Global Dihydroartemisinin Price by Type (2020-2025)

5.3.2 Global Dihydroartemisinin Price Forecast by Type (2026-2031)

6 Market Size by Application

6.1 Global Sales by Application

6.1.1 Global Dihydroartemisinin Historical Sales by Application (2020-2025)

6.1.2 Global Dihydroartemisinin Forecasted Sales by Application (2026-2031)

6.1.3 Global Dihydroartemisinin Sales Market Share by Application (2020-2031)

6.2 Global Revenue by Application

6.2.1 Global Dihydroartemisinin Historical Revenue by Application (2020-2025)

6.2.2 Global Dihydroartemisinin Forecasted Revenue by Application (2026-2031)

6.2.3 Global Dihydroartemisinin Revenue Market Share by Application (2020-2031)

6.3 Global Price by Application

6.3.1 Global Dihydroartemisinin Price by Application (2020-2025)

6.3.2 Global Dihydroartemisinin Price Forecast by Application (2026-2031)

7 US & Canada

7.1 US & Canada Market Size by Type

7.1.1 US & Canada Dihydroartemisinin Sales by Type (2020-2031)

7.1.2 US & Canada Dihydroartemisinin Revenue by Type (2020-2031)

7.2 US & Canada Market Size by Application

7.2.1 US & Canada Dihydroartemisinin Sales by Application (2020-2031)

7.2.2 US & Canada Dihydroartemisinin Revenue by Application (2020-2031)

7.3 US & Canada Market Size by Country

7.3.1 US & Canada Dihydroartemisinin Revenue by Country: 2020 VS 2024 VS 2031

7.3.2 US & Canada Dihydroartemisinin Revenue by Country (2020-2031)

7.3.3 US & Canada Dihydroartemisinin Sales by Country (2020-2031)

7.3.4 US

7.3.5 Canada

8 Europe

8.1 Europe Market Size by Type

8.1.1 Europe Dihydroartemisinin Sales by Type (2020-2031)

8.1.2 Europe Dihydroartemisinin Revenue by Type (2020-2031)

8.2 Europe Market Size by Application

8.2.1 Europe Dihydroartemisinin Sales by Application (2020-2031)

8.2.2 Europe Dihydroartemisinin Revenue by Application (2020-2031)

8.3 Europe Market Size by Country

8.3.1 Europe Dihydroartemisinin Revenue by Country: 2020 VS 2024 VS 2031

8.3.2 Europe Dihydroartemisinin Sales by Country (2020-2031)

8.3.3 Europe Dihydroartemisinin Revenue by Country (2020-2031)

8.3.4 Germany

8.3.5 France

8.3.6 U.K.

8.3.7 Italy

8.3.8 Russia

9 China

9.1 China Market Size by Type

9.1.1 China Dihydroartemisinin Sales by Type (2020-2031)

9.1.2 China Dihydroartemisinin Revenue by Type (2020-2031)

9.2 China Market Size by Application

9.2.1 China Dihydroartemisinin Sales by Application (2020-2031)

9.2.2 China Dihydroartemisinin Revenue by Application (2020-2031)

10 Asia (excluding China)

10.1 Asia Market Size by Type

10.1.1 Asia Dihydroartemisinin Sales by Type (2020-2031)

10.1.2 Asia Dihydroartemisinin Revenue by Type (2020-2031)

10.2 Asia Market Size by Application

10.2.1 Asia Dihydroartemisinin Sales by Application (2020-2031)

10.2.2 Asia Dihydroartemisinin Revenue by Application (2020-2031)

10.3 Asia Market Size by Region

10.3.1 Asia Dihydroartemisinin Revenue by Region: 2020 VS 2024 VS 2031

10.3.2 Asia Dihydroartemisinin Revenue by Region (2020-2031)

10.3.3 Asia Dihydroartemisinin Sales by Region (2020-2031)

10.3.4 Japan

10.3.5 South Korea

10.3.6 China Taiwan

10.3.7 Southeast Asia

10.3.8 India

11 Middle East, Africa and Latin America

11.1 Middle East, Africa and Latin America Market Size by Type

11.1.1 Middle East, Africa and Latin America Dihydroartemisinin Sales by Type (2020-2031)

11.1.2 Middle East, Africa and Latin America Dihydroartemisinin Revenue by Type (2020-2031)

11.2 Middle East, Africa and Latin America Market Size by Application

11.2.1 Middle East, Africa and Latin America Dihydroartemisinin Sales by Application (2020-2031)

11.2.2 Middle East, Africa and Latin America Dihydroartemisinin Revenue by Application (2020-2031)

11.3 Middle East, Africa and Latin America Market Size by Country

11.3.1 Middle East, Africa and Latin America Dihydroartemisinin Revenue by Country: 2020 VS 2024 VS 2031

11.3.2 Middle East, Africa and Latin America Dihydroartemisinin Revenue by Country (2020-2031)

11.3.3 Middle East, Africa and Latin America Dihydroartemisinin Sales by Country (2020-2031)

11.3.4 Brazil

11.3.5 Mexico

11.3.6 Turkey

11.3.7 Israel

11.3.8 GCC Countries

12 Corporate Profile

12.1 Ion Science

12.1.1 Ion Science Corporation Information

12.1.2 Ion Science Overview

12.1.3 Ion Science Dihydroartemisinin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.1.4 Ion Science Dihydroartemisinin Product Model Numbers, Pictures, Descriptions and Specifications

12.1.5 Ion Science Recent Developments

12.2 Nanjing Rich Native Animal Products

12.2.1 Nanjing Rich Native Animal Products Corporation Information

12.2.2 Nanjing Rich Native Animal Products Overview

12.2.3 Nanjing Rich Native Animal Products Dihydroartemisinin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.2.4 Nanjing Rich Native Animal Products Dihydroartemisinin Product Model Numbers, Pictures, Descriptions and Specifications

12.2.5 Nanjing Rich Native Animal Products Recent Developments

12.3 Tobacco Products

12.3.1 Tobacco Products Corporation Information

12.3.2 Tobacco Products Overview

12.3.3 Tobacco Products Dihydroartemisinin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.3.4 Tobacco Products Dihydroartemisinin Product Model Numbers, Pictures, Descriptions and Specifications

12.3.5 Tobacco Products Recent Developments

12.4 Grey Essential Oils

12.4.1 Grey Essential Oils Corporation Information

12.4.2 Grey Essential Oils Overview

12.4.3 Grey Essential Oils Dihydroartemisinin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.4.4 Grey Essential Oils Dihydroartemisinin Product Model Numbers, Pictures, Descriptions and Specifications

12.4.5 Grey Essential Oils Recent Developments

12.5 Sanofi

12.5.1 Sanofi Corporation Information

12.5.2 Sanofi Overview

12.5.3 Sanofi Dihydroartemisinin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.5.4 Sanofi Dihydroartemisinin Product Model Numbers, Pictures, Descriptions and Specifications

12.5.5 Sanofi Recent Developments

12.6 KPC Pharmaceuticals

12.6.1 KPC Pharmaceuticals Corporation Information

12.6.2 KPC Pharmaceuticals Overview

12.6.3 KPC Pharmaceuticals Dihydroartemisinin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.6.4 KPC Pharmaceuticals Dihydroartemisinin Product Model Numbers, Pictures, Descriptions and Specifications

12.6.5 KPC Pharmaceuticals Recent Developments

12.7 Guangxi Xiancaotang Pharmaceutical

12.7.1 Guangxi Xiancaotang Pharmaceutical Corporation Information

12.7.2 Guangxi Xiancaotang Pharmaceutical Overview

12.7.3 Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.7.4 Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Product Model Numbers, Pictures, Descriptions and Specifications

12.7.5 Guangxi Xiancaotang Pharmaceutical Recent Developments

12.8 Guilin Pharmaceutical

12.8.1 Guilin Pharmaceutical Corporation Information

12.8.2 Guilin Pharmaceutical Overview

12.8.3 Guilin Pharmaceutical Dihydroartemisinin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.8.4 Guilin Pharmaceutical Dihydroartemisinin Product Model Numbers, Pictures, Descriptions and Specifications

12.8.5 Guilin Pharmaceutical Recent Developments

12.9 Kerui Nanhai Pharmaceutical

12.9.1 Kerui Nanhai Pharmaceutical Corporation Information

12.9.2 Kerui Nanhai Pharmaceutical Overview

12.9.3 Kerui Nanhai Pharmaceutical Dihydroartemisinin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.9.4 Kerui Nanhai Pharmaceutical Dihydroartemisinin Product Model Numbers, Pictures, Descriptions and Specifications

12.9.5 Kerui Nanhai Pharmaceutical Recent Developments

12.10 Shanghai Natural Bio-engineering

12.10.1 Shanghai Natural Bio-engineering Corporation Information

12.10.2 Shanghai Natural Bio-engineering Overview

12.10.3 Shanghai Natural Bio-engineering Dihydroartemisinin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.10.4 Shanghai Natural Bio-engineering Dihydroartemisinin Product Model Numbers, Pictures, Descriptions and Specifications

12.10.5 Shanghai Natural Bio-engineering Recent Developments

12.11 Novanat Bioresource

12.11.1 Novanat Bioresource Corporation Information

12.11.2 Novanat Bioresource Overview

12.11.3 Novanat Bioresource Dihydroartemisinin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.11.4 Novanat Bioresource Dihydroartemisinin Product Model Numbers, Pictures, Descriptions and Specifications

12.11.5 Novanat Bioresource Recent Developments

12.12 Botanical Extracts EPZ Ltd

12.12.1 Botanical Extracts EPZ Ltd Corporation Information

12.12.2 Botanical Extracts EPZ Ltd Overview

12.12.3 Botanical Extracts EPZ Ltd Dihydroartemisinin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.12.4 Botanical Extracts EPZ Ltd Dihydroartemisinin Product Model Numbers, Pictures, Descriptions and Specifications

12.12.5 Botanical Extracts EPZ Ltd Recent Developments

12.13 Skant Healthcare

12.13.1 Skant Healthcare Corporation Information

12.13.2 Skant Healthcare Overview

12.13.3 Skant Healthcare Dihydroartemisinin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.13.4 Skant Healthcare Dihydroartemisinin Product Model Numbers, Pictures, Descriptions and Specifications

12.13.5 Skant Healthcare Recent Developments

12.14 Micro Orgo Chem

12.14.1 Micro Orgo Chem Corporation Information

12.14.2 Micro Orgo Chem Overview

12.14.3 Micro Orgo Chem Dihydroartemisinin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.14.4 Micro Orgo Chem Dihydroartemisinin Product Model Numbers, Pictures, Descriptions and Specifications

12.14.5 Micro Orgo Chem Recent Developments

13 Industry Chain and Sales Channels Analysis

13.1 Dihydroartemisinin Industry Chain Analysis

13.2 Dihydroartemisinin Key Raw Materials

13.2.1 Key Raw Materials

13.2.2 Raw Materials Key Suppliers

13.3 Dihydroartemisinin Production Mode & Process

13.4 Dihydroartemisinin Sales and Marketing

13.4.1 Dihydroartemisinin Sales Channels

13.4.2 Dihydroartemisinin Distributors

13.5 Dihydroartemisinin Customers

14 Dihydroartemisinin Market Dynamics

14.1 Dihydroartemisinin Industry Trends

14.2 Dihydroartemisinin Market Drivers

14.3 Dihydroartemisinin Market Challenges

14.4 Dihydroartemisinin Market Restraints

15 Key Findings in the Global Dihydroartemisinin Study

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.1.1 Research Programs/Design

16.1.1.2 Market Size Estimation

16.1.1.3 Market Breakdown and Data Triangulation

16.1.2 Data Source

16.1.2.1 Secondary Sources

16.1.2.2 Primary Sources

16.2 Author Details

TABLE OF FIGURES

List of Tables

Table 1. Global Dihydroartemisinin Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Key Manufacturers of Pharmaceutical Grade

Table 3. Key Manufacturers of Industrial Grade

Table 4. Global Dihydroartemisinin Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 5. Global Dihydroartemisinin Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (MT)

Table 6. Global Production by Region (2020-2031) & (MT)

Table 7. Global Production Market Share by Region (2020-2031)

Table 8. Global Dihydroartemisinin Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 9. Global Revenue by Region (2020-2031) & (US$ Million)

Table 10. Global Revenue Market Share by Region (2020-2031)

Table 11. Global Dihydroartemisinin Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (MT)

Table 12. Global Dihydroartemisinin Sales by Region (2020-2031) & (MT)

Table 13. Global Sales Market Share by Region (2020-2031)

Table 14. Global Dihydroartemisinin Sales by Manufacturers (2020-2025) & (MT)

Table 15. Global Dihydroartemisinin Sales Share by Manufacturers (2020-2025)

Table 16. Global Dihydroartemisinin Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 17. Global Dihydroartemisinin Revenue Market Share by Manufacturers (2020-2025)

Table 18. Dihydroartemisinin Price by Manufacturers (2020-2025) & (USD/MT)

Table 19. Global Key Players of Dihydroartemisinin, Industry Ranking, 2023 VS 2024

Table 20. Global Dihydroartemisinin Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 21. Global Dihydroartemisinin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dihydroartemisinin as of 2024)

Table 22. Global Key Manufacturers of Dihydroartemisinin, Manufacturing Base Distribution and Headquarters

Table 23. Global Key Manufacturers of Dihydroartemisinin, Product Offered and Application

Table 24. Global Key Manufacturers of Dihydroartemisinin, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Dihydroartemisinin Sales by Type (2020-2025) & (MT)

Table 27. Global Dihydroartemisinin Sales by Type (2026-2031) & (MT)

Table 28. Global Sales Share by Type (2020-2031)

Table 29. Global Dihydroartemisinin Revenue by Type (2020-2025) & (US$ Million)

Table 30. Global Dihydroartemisinin Revenue by Type (2026-2031) & (US$ Million)

Table 31. Global Revenue Share by Type (2020-2031)

Table 32. Dihydroartemisinin Price by Type (2020-2025) & (USD/MT)

Table 33. Global Dihydroartemisinin Price Forecast by Type (2026-2031) & (USD/MT)

Table 34. Global Dihydroartemisinin Sales by Application (2020-2025) & (MT)

Table 35. Global Dihydroartemisinin Sales by Application (2026-2031) & (MT)

Table 36. Global Sales Share by Application (2020-2031)

Table 37. Global Dihydroartemisinin Revenue by Application (2020-2025) & (US$ Million)

Table 38. Global Dihydroartemisinin Revenue by Application (2026-2031) & (US$ Million)

Table 39. Global Revenue Share by Application (2020-2031)

Table 40. Dihydroartemisinin Price by Application (2020-2025) & (USD/MT)

Table 41. Global Dihydroartemisinin Price Forecast by Application (2026-2031) & (USD/MT)

Table 42. US & Canada Sales by Type (2020-2031) & (MT)

Table 43. US & Canada Revenue by Type (2020-2031) & (US$ Million)

Table 44. US & Canada Sales by Application (2020-2031) & (MT)

Table 45. US & Canada Revenue by Application (2020-2031) & (US$ Million)

Table 46. US & Canada Dihydroartemisinin Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 47. US & Canada Revenue by Country (2020-2031) & (US$ Million)

Table 48. US & Canada Sales by Country (2020-2031) & (MT)

Table 49. Europe Sales by Type (2020-2031) & (MT)

Table 50. Europe Revenue by Type (2020-2031) & (US$ Million)

Table 51. Europe Sales by Application (2020-2031) & (MT)

Table 52. Europe Revenue by Application (2020-2031) & (US$ Million)

Table 53. Europe Dihydroartemisinin Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 54. Europe Sales by Country (2020-2031) & (MT)

Table 55. Europe Revenue by Country (2020-2031) & (US$ Million)

Table 56. China Sales by Type (2020-2031) & (MT)

Table 57. China Revenue by Type (2020-2031) & (US$ Million)

Table 58. China Sales by Application (2020-2031) & (MT)

Table 59. China Revenue by Application (2020-2031) & (US$ Million)

Table 60. Asia Sales by Type (2020-2031) & (MT)

Table 61. Asia Revenue by Type (2020-2031) & (US$ Million)

Table 62. Asia Sales by Application (2020-2031) & (MT)

Table 63. Asia Revenue by Application (2020-2031) & (US$ Million)

Table 64. Asia Dihydroartemisinin Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 65. Asia Revenue by Region (2020-2031) & (US$ Million)

Table 66. Asia Sales by Region (2020-2031) & (MT)

Table 67. Middle East, Africa and Latin America Sales by Type (2020-2031) & (MT)

Table 68. Middle East, Africa and Latin America Revenue by Type (2020-2031) & (US$ Million)

Table 69. Middle East, Africa and Latin America Sales by Application (2020-2031) & (MT)

Table 70. Middle East, Africa and Latin America Revenue by Application (2020-2031) & (US$ Million)

Table 71. Middle East, Africa and Latin America Dihydroartemisinin Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 72. Middle East, Africa and Latin America Revenue by Country (2020-2031) & (US$ Million)

Table 73. Middle East, Africa and Latin America Sales by Country (2020-2031) & (MT)

Table 74. Ion Science Corporation Information

Table 75. Ion Science Description and Major Businesses

Table 76. Ion Science Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 77. Ion Science Product Model Numbers, Pictures, Descriptions and Specifications

Table 78. Ion Science Recent Developments

Table 79. Nanjing Rich Native Animal Products Corporation Information

Table 80. Nanjing Rich Native Animal Products Description and Major Businesses

Table 81. Nanjing Rich Native Animal Products Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 82. Nanjing Rich Native Animal Products Product Model Numbers, Pictures, Descriptions and Specifications

Table 83. Nanjing Rich Native Animal Products Recent Developments

Table 84. Tobacco Products Corporation Information

Table 85. Tobacco Products Description and Major Businesses

Table 86. Tobacco Products Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 87. Tobacco Products Product Model Numbers, Pictures, Descriptions and Specifications

Table 88. Tobacco Products Recent Developments

Table 89. Grey Essential Oils Corporation Information

Table 90. Grey Essential Oils Description and Major Businesses

Table 91. Grey Essential Oils Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 92. Grey Essential Oils Product Model Numbers, Pictures, Descriptions and Specifications

Table 93. Grey Essential Oils Recent Developments

Table 94. Sanofi Corporation Information

Table 95. Sanofi Description and Major Businesses

Table 96. Sanofi Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 97. Sanofi Product Model Numbers, Pictures, Descriptions and Specifications

Table 98. Sanofi Recent Developments

Table 99. KPC Pharmaceuticals Corporation Information

Table 100. KPC Pharmaceuticals Description and Major Businesses

Table 101. KPC Pharmaceuticals Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 102. KPC Pharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications

Table 103. KPC Pharmaceuticals Recent Developments

Table 104. Guangxi Xiancaotang Pharmaceutical Corporation Information

Table 105. Guangxi Xiancaotang Pharmaceutical Description and Major Businesses

Table 106. Guangxi Xiancaotang Pharmaceutical Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 107. Guangxi Xiancaotang Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications

Table 108. Guangxi Xiancaotang Pharmaceutical Recent Developments

Table 109. Guilin Pharmaceutical Corporation Information

Table 110. Guilin Pharmaceutical Description and Major Businesses

Table 111. Guilin Pharmaceutical Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 112. Guilin Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications

Table 113. Guilin Pharmaceutical Recent Developments

Table 114. Kerui Nanhai Pharmaceutical Corporation Information

Table 115. Kerui Nanhai Pharmaceutical Description and Major Businesses

Table 116. Kerui Nanhai Pharmaceutical Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 117. Kerui Nanhai Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications

Table 118. Kerui Nanhai Pharmaceutical Recent Developments

Table 119. Shanghai Natural Bio-engineering Corporation Information

Table 120. Shanghai Natural Bio-engineering Description and Major Businesses

Table 121. Shanghai Natural Bio-engineering Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 122. Shanghai Natural Bio-engineering Product Model Numbers, Pictures, Descriptions and Specifications

Table 123. Shanghai Natural Bio-engineering Recent Developments

Table 124. Novanat Bioresource Corporation Information

Table 125. Novanat Bioresource Description and Major Businesses

Table 126. Novanat Bioresource Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 127. Novanat Bioresource Product Model Numbers, Pictures, Descriptions and Specifications

Table 128. Novanat Bioresource Recent Developments

Table 129. Botanical Extracts EPZ Ltd Corporation Information

Table 130. Botanical Extracts EPZ Ltd Description and Major Businesses

Table 131. Botanical Extracts EPZ Ltd Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 132. Botanical Extracts EPZ Ltd Product Model Numbers, Pictures, Descriptions and Specifications

Table 133. Botanical Extracts EPZ Ltd Recent Developments

Table 134. Skant Healthcare Corporation Information

Table 135. Skant Healthcare Description and Major Businesses

Table 136. Skant Healthcare Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 137. Skant Healthcare Product Model Numbers, Pictures, Descriptions and Specifications

Table 138. Skant Healthcare Recent Developments

Table 139. Micro Orgo Chem Corporation Information

Table 140. Micro Orgo Chem Description and Major Businesses

Table 141. Micro Orgo Chem Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 142. Micro Orgo Chem Product Model Numbers, Pictures, Descriptions and Specifications

Table 143. Micro Orgo Chem Recent Developments

Table 144. Key Raw Materials Lists

Table 145. Raw Materials Key Suppliers Lists

Table 146. Distributors List

Table 147. Customers List

Table 148. Market Trends

Table 149. Market Drivers

Table 150. Market Challenges

Table 151. Market Restraints

Table 152. Research Programs/Design for This Report

Table 153. Key Data Information from Secondary Sources

Table 154. Key Data Information from Primary Sources

List of Figures

Figure 1. Dihydroartemisinin Product Picture

Figure 2. Global Dihydroartemisinin Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Dihydroartemisinin Market Share by Type: 2024 & 2031

Figure 4. Pharmaceutical Grade Product Picture

Figure 5. Industrial Grade Product Picture

Figure 6. Global Dihydroartemisinin Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 7. Global Dihydroartemisinin Market Share by Application in 2024 & 2031

Figure 8. Malaria Treatment

Figure 9. Scientific Research

Figure 10. Others

Figure 11. Dihydroartemisinin Report Years Considered

Figure 12. Global Dihydroartemisinin Capacity, Production and Utilization (2020-2031) & (MT)

Figure 13. Global Dihydroartemisinin Production by Region (2020 – 2031) (MT)

Figure 14. Global Dihydroartemisinin Production Market Share by Region in Percentage: 2024 Versus 2031

Figure 15. Global Dihydroartemisinin Production Market Share by Region (2020-2031)

Figure 16. Dihydroartemisinin Production Growth Rate in North America (2020-2031) & (MT)

Figure 17. Dihydroartemisinin Production Growth Rate in Europe (2020-2031) & (MT)

Figure 18. Dihydroartemisinin Production Growth Rate in China (2020-2031) & (MT)

Figure 19. Dihydroartemisinin Production Growth Rate in Japan (2020-2031) & (MT)

Figure 20. Global Dihydroartemisinin Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 21. Global Dihydroartemisinin Revenue (2020-2031) & (US$ Million)

Figure 22. Global Dihydroartemisinin Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 23. Global Dihydroartemisinin Revenue Market Share by Region in Percentage: 2024 Versus 2031

Figure 24. Global Dihydroartemisinin Revenue Market Share by Region (2020-2031)

Figure 25. Global Dihydroartemisinin Sales (2020-2031) & (MT)

Figure 26. Global Dihydroartemisinin Sales (CAGR) by Region: 2020 VS 2024 VS 2031 (MT)

Figure 27. Global Dihydroartemisinin Sales Market Share by Region (2020-2031)

Figure 28. US & Canada Dihydroartemisinin Sales YoY (2020-2031) & (MT)

Figure 29. US & Canada Dihydroartemisinin Revenue YoY (2020-2031) & (US$ Million)

Figure 30. Europe Dihydroartemisinin Sales YoY (2020-2031) & (MT)

Figure 31. Europe Dihydroartemisinin Revenue YoY (2020-2031) & (US$ Million)

Figure 32. China Dihydroartemisinin Sales YoY (2020-2031) & (MT)

Figure 33. China Dihydroartemisinin Revenue YoY (2020-2031) & (US$ Million)

Figure 34. Asia (excluding China) Dihydroartemisinin Sales YoY (2020-2031) & (MT)

Figure 35. Asia (excluding China) Dihydroartemisinin Revenue YoY (2020-2031) & (US$ Million)

Figure 36. Middle East, Africa and Latin America Dihydroartemisinin Sales YoY (2020-2031) & (MT)

Figure 37. Middle East, Africa and Latin America Dihydroartemisinin Revenue YoY (2020-2031) & (US$ Million)

Figure 38. Global Dihydroartemisinin Sales Share by Manufacturers (2024)

Figure 39. The Dihydroartemisinin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2024

Figure 40. Global Dihydroartemisinin Revenue Share by Manufacturers (2024)

Figure 41. The Top 5 and 10 Largest Manufacturers of Dihydroartemisinin in the World: Market Share by Dihydroartemisinin Revenue in 2024

Figure 42. Global Dihydroartemisinin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 43. Global Dihydroartemisinin Sales Market Share by Type (2020-2031)

Figure 44. Global Dihydroartemisinin Revenue Market Share by Type (2020-2031)

Figure 45. Global Dihydroartemisinin Sales Market Share by Application (2020-2031)

Figure 46. Global Dihydroartemisinin Revenue Market Share by Application (2020-2031)

Figure 47. US & Canada Dihydroartemisinin Sales Market Share by Type (2020-2031)

Figure 48. US & Canada Dihydroartemisinin Revenue Market Share by Type (2020-2031)

Figure 49. US & Canada Dihydroartemisinin Sales Market Share by Application (2020-2031)

Figure 50. US & Canada Dihydroartemisinin Revenue Market Share by Application (2020-2031)

Figure 51. US & Canada Dihydroartemisinin Revenue Share by Country (2020-2031)

Figure 52. US & Canada Dihydroartemisinin Sales Share by Country (2020-2031)

Figure 53. US Dihydroartemisinin Revenue (2020-2031) & (US$ Million)

Figure 54. Canada Dihydroartemisinin Revenue (2020-2031) & (US$ Million)

Figure 55. Europe Dihydroartemisinin Sales Market Share by Type (2020-2031)

Figure 56. Europe Dihydroartemisinin Revenue Market Share by Type (2020-2031)

Figure 57. Europe Dihydroartemisinin Sales Market Share by Application (2020-2031)

Figure 58. Europe Dihydroartemisinin Revenue Market Share by Application (2020-2031)

Figure 59. Europe Dihydroartemisinin Sales Share by Country (2020-2031)

Figure 60. Europe Dihydroartemisinin Revenue Share by Country (2020-2031)

Figure 61. Germany Dihydroartemisinin Revenue (2020-2031) & (US$ Million)

Figure 62. France Dihydroartemisinin Revenue (2020-2031) & (US$ Million)

Figure 63. U.K. Dihydroartemisinin Revenue (2020-2031) & (US$ Million)

Figure 64. Italy Dihydroartemisinin Revenue (2020-2031) & (US$ Million)

Figure 65. Russia Dihydroartemisinin Revenue (2020-2031) & (US$ Million)

Figure 66. China Dihydroartemisinin Sales Market Share by Type (2020-2031)

Figure 67. China Dihydroartemisinin Revenue Market Share by Type (2020-2031)

Figure 68. China Dihydroartemisinin Sales Market Share by Application (2020-2031)

Figure 69. China Dihydroartemisinin Revenue Market Share by Application (2020-2031)

Figure 70. Asia Dihydroartemisinin Sales Market Share by Type (2020-2031)

Figure 71. Asia Dihydroartemisinin Revenue Market Share by Type (2020-2031)

Figure 72. Asia Dihydroartemisinin Sales Market Share by Application (2020-2031)

Figure 73. Asia Dihydroartemisinin Revenue Market Share by Application (2020-2031)

Figure 74. Asia Dihydroartemisinin Revenue Share by Region (2020-2031)

Figure 75. Asia Dihydroartemisinin Sales Share by Region (2020-2031)

Figure 76. Japan Dihydroartemisinin Revenue (2020-2031) & (US$ Million)

Figure 77. South Korea Dihydroartemisinin Revenue (2020-2031) & (US$ Million)

Figure 78. China Taiwan Dihydroartemisinin Revenue (2020-2031) & (US$ Million)

Figure 79. Southeast Asia Dihydroartemisinin Revenue (2020-2031) & (US$ Million)

Figure 80. India Dihydroartemisinin Revenue (2020-2031) & (US$ Million)

Figure 81. Middle East, Africa and Latin America Dihydroartemisinin Sales Market Share by Type (2020-2031)

Figure 82. Middle East, Africa and Latin America Dihydroartemisinin Revenue Market Share by Type (2020-2031)

Figure 83. Middle East, Africa and Latin America Dihydroartemisinin Sales Market Share by Application (2020-2031)

Figure 84. Middle East, Africa and Latin America Dihydroartemisinin Revenue Market Share by Application (2020-2031)

Figure 85. Middle East, Africa and Latin America Dihydroartemisinin Revenue Share by Country (2020-2031)

Figure 86. Middle East, Africa and Latin America Dihydroartemisinin Sales Share by Country (2020-2031)

Figure 87. Brazil Dihydroartemisinin Revenue (2020-2031) & (US$ Million)

Figure 88. Mexico Dihydroartemisinin Revenue (2020-2031) & (US$ Million)

Figure 89. Turkey Dihydroartemisinin Revenue (2020-2031) & (US$ Million)

Figure 90. Israel Dihydroartemisinin Revenue (2020-2031) & (US$ Million)

Figure 91. GCC Countries Dihydroartemisinin Revenue (2020-2031) & (US$ Million)

Figure 92. Value Chain

Figure 93. Dihydroartemisinin Production Process

Figure 94. Channels of Distribution (Direct Vs Distribution)

Figure 95. Bottom-up and Top-down Approaches for This Report

Figure 96. Data Triangulation

Figure 97. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Dihydroartemisinin market? zhanKai

The top companies in the global Dihydroartemisinin market are Ion Science、Nanjing Rich Native Animal Products、Tobacco Products.

Related Reports

Global Dihydroartemisinin Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Dihydroartemisinin market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 94
USD 4250.00
(Single User License)
Global Dihydroartemisinin Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Dihydroartemisinin market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 159
USD 4900.00
(Single User License)
Dihydroartemisinin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Dihydroartemisinin was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-03-05
Pages: 125
USD 3950.00
(Single User License)
Global Dihydroartemisinin Market Research Report 2026
The global Dihydroartemisinin market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-03-05
Pages: 138
USD 2900.00
(Single User License)
Global Dihydroartemisinin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Dihydroartemisinin market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 154
USD 4900.00
(Single User License)
Dihydroartemisinin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Dihydroartemisinin was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-06-04
Pages: 114
USD 3950.00
(Single User License)
Global Dihydroartemisinin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Dihydroartemisinin market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-06-04
Pages: 92
USD 4250.00
(Single User License)
Global Dihydroartemisinin Market Research Report 2025
The global market for Dihydroartemisinin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-06-04
Pages: 100
USD 2900.00
(Single User License)
Dihydroartemisinin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Dihydroartemisinin was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 97
USD 3950.00
(Single User License)
Dihydroartemisinin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Dihydroartemisinin was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-16
Pages: 98
USD 3950.00
(Single User License)

Global Dihydroartemisinin Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Dihydroartemisinin market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 94
USD 4250.00 (Single User License)
Global Dihydroartemisinin Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Dihydroartemisinin market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 159
USD 4900.00 (Single User License)
Dihydroartemisinin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Dihydroartemisinin was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-03-05
Pages: 125
USD 3950.00 (Single User License)
Global Dihydroartemisinin Market Research Report 2026
The global Dihydroartemisinin market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-03-05
Pages: 138
USD 2900.00 (Single User License)
Global Dihydroartemisinin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Dihydroartemisinin market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 154
USD 4900.00 (Single User License)
Dihydroartemisinin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Dihydroartemisinin was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-06-04
Pages: 114
USD 3950.00 (Single User License)
Global Dihydroartemisinin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Dihydroartemisinin market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-06-04
Pages: 92
USD 4250.00 (Single User License)
Global Dihydroartemisinin Market Research Report 2025
The global market for Dihydroartemisinin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-06-04
Pages: 100
USD 2900.00 (Single User License)
Dihydroartemisinin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Dihydroartemisinin was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 97
USD 3950.00 (Single User License)
Dihydroartemisinin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Dihydroartemisinin was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-16
Pages: 98
USD 3950.00 (Single User License)